Craft

JCR Pharmaceuticals

Stock Price

¥615

2024-07-03

Market Capitalization

¥77.3 B

2024-07-03

Revenue

¥42.9 B

FY, 2024

JCR Pharmaceuticals Summary

Company Summary

Overview
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. It is engaged in the research and discovery of therapeutic drugs for lysosomal storage diseases. The company focuses on blood-brain barrier penetration technology, tissue-targeting technology, as well as cell therapy and regenerative medicine.
Type
Public
Status
Active
Founded
1975
HQ
Ashiya, JP | view all locations
Website
https://www.jcrpharm.co.jp/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Shin Ashida, Chairman, President and CEO

    • Toru Ashida, Vice President

      • Hiroyuki Sonoda, Senior Executive Director

        • Mathias Schmidt, Senior Executive Director

          LocationsView all

          5 locations detected

          • Ashiya, Hyogo HQ

            Japan

            3-19 Kasuga-cho

          • Kobe, Hyogo

            Japan

            1-2-3 Murotani, Nishi-ku

          • Kobe, Hyogo

            Japan

            1-6-6 Murotani, Nishi-ku

          • Kobe, Hyogo

            Japan

            2-2-10 Murotani, Nishi-ku

          • Kobe, Hyogo

            Japan

            3-2-61 Takatsukadai, Nishi-ku

          JCR Pharmaceuticals Financials

          Summary Financials

          Revenue (FY, 2024)
          ¥42.9B
          Gross profit (FY, 2024)
          ¥34.4B
          Net income (FY, 2024)
          ¥5.5B
          Cash (FY, 2024)
          ¥18.8B
          EBIT (FY, 2024)
          ¥6.6B
          Enterprise value
          $81.8B

          Footer menu